BlogHeader.png

Alcami Expands its Sterile Fill-Finish Capacity with Acquisition of TriPharm Services

Transaction Advances Alcami’s Strategic Plan by Adding Scale in Attractive and Growing Parenteral Markets

Alcami Investors Make Additional Equity Investment Alongside Ampersand Capital Partners to Fund Expansion

Durham, NC (USA) – January 17, 2020 – Alcami Corporation (“Alcami”), a leading provider of fully-integrated custom end-to-end solutions for the pharmaceutical and biologics industries, today announced it has acquired TriPharm Services (“TriPharm”), a new state-of-the-art sterile fill-finish manufacturing center located near Research Triangle Park, North Carolina. The acquisition of TriPharm follows the recently announced $17 million expansion of Alcami’s sterile fill-finish facility in Charleston, South Carolina.

Topics: Company News Parenteral Manufacturing

Alcami Announces Sale of its Weert, Netherlands Facility

Next Step in Alcami’s Strategic Plan to Focus its Platform on High-Growth Market Segments

Durham, NC (USA) – January 8, 2020 – Alcami Corporation, a leading provider of fully-integrated custom end-to-end solutions for the pharmaceutical and biologics industries, today announced the sale of its preclinical and early stage active pharmaceutical ingredient (API) facility in Weert, Netherlands to MercachemSyncom, a leading mid-sized European integrated drug-discovery and development contract research organization. Terms were not disclosed. 

Topics: Company News API Contract Manufacturing Services Contract Development Services

Alcami Corporation Expanding Operations in Charleston County

Durham, NC (USA) – December 17, 2019 – Alcami Corporation, a leading provider of fully-integrated custom end-to-end solutions for the pharmaceutical and biologics industries, today announced plans to expand the company’s current operations in Charleston County. The $17 million investment is expected to create 30 new jobs.

Topics: Company News Parenteral Manufacturing

Alcami Featured in Wisconsin Biohealth Industry Profile

Alcami is featured among Wisconsin’s leading innovative global health and technology companies in a recent industry profile published by the Wisconsin Economic Development Corporation (WEDC). 

WEDC leads economic development efforts for the state by advancing and maximizing opportunities in Wisconsin for businesses, communities, and people to thrive in a globally competitive environment.

Topics: Company News CDMO Contract Manufacturing Services Contract Development Services

Alcami Launches New Rapid Sterility Testing Services

Durham, NC (USA) – October 8, 2019 – Alcami Corporation, a leading provider of fully-integrated custom end-to-end solutions for the pharmaceutical and biologics industries, today announced the launch of its new rapid sterility offering, a service that leverages cutting-edge microbiological testing technology to deliver significantly faster testing results to clients. Alcami invested in the Milliflex® Rapid System for the rapid sterility test, which uses adenosine triphosphate (ATP) bioluminescence for detection of microorganisms after five days.

Topics: Company News Microbiology Rapid Sterility

Alcami and Wisconsin Department of Natural Resources Enter Third Year of Environmental Stewardship Program

Environmental protection, sustainable conservation, and natural habitat preservation remain key components of Alcami’s community outreach activities, and for the third consecutive year, company volunteers collaborated with Wisconsin Department of Natural Resources (DNR) trail coordinators and park superintendents to improve and renovate the Pike Lake Unit of the Kettle Moraine State Forest – one of the Wisconsin State Park System’s most popular destinations.

Topics: Company News Alcami in Action

Video: High-Potency APIs

The increasing trend of using highly potent active pharmaceutical ingredients (HPAPIs) in new drug development candidates has created a tremendous demand for high containment development and production capabilities.

Alcami is a trusted partner for the development and manufacture of HPAPIs. Our Germantown Center of Excellence for API development, scale up, and commercialization provides an exceptional platform for control strategy at each phase of the development process through a series of investments targeted at infrastructure, workforce, tools, and technology. Alcami’s extensive regulatory expertise allows innovators to execute all parts of development and manufacturing in one US‐based location to support the launch of tomorrow’s medicines.

Topics: Company News HPAPI API Videos

Video: Animal Health

Alcami will support your animal health products, both companion and livestock, with precise attention to quality by design and process development. We have experience advancing over 50 animal health products from concept through commercialization, with services ranging from analytical support to manufacturing of active pharmaceutical ingredients (APIs), oral solid dose (OSD) products, and sterile (liquid and lyophilized) products. 

Topics: Company News Analytical Testing Analytical Development API Drug Product Videos Animal Health

Alcami Pays Tribute to Fallen Patriots this Memorial Day

Alcami joined the nation in remembering and honoring fallen members of the U.S. Armed Forces this Memorial Day with a donation to the Purple Heart Foundation and a strong public showing of support for longtime Alcami employee and Vietnam veteran, Herman Anthony.

In a special tribute to the brave men and women who sacrificed their lives in service to our country, Anthony was invited by the Milwaukee Brewers to participate in a May 26 ceremony on the Miller Park playing field during the national anthem.

Topics: Company News Alcami in Action

Alcami Supports Homestead High School’s Varsity Robotics Club

Alcami continues to make science, technology, engineering, and mathematics (STEM) education and training initiatives a priority in 2019, this time partnering with Homestead High School in Mequon, Wisconsin, to support the school’s growing robotics club. The company has agreed to sponsor Homestead’s 2019 competitions and demonstrations, which will help its club purchase new computers and 3D printers. On average, teams invest approximately $4,000 to build a robot from the ground up and participate in competitions.

Topics: Company News Alcami in Action